These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 13474411)

  • 1. [Treatment of early cavitary pulmonary tuberculosis with combined streptomycin and PAS in intravenous perfusion, prednisone, neuroregulatory drugs and aerosols of bronchodilatatory and fibrinopyolytic drugs].
    BORSELLA C
    G Ital Della Tuberc; 1957; 11(4):225-33. PubMed ID: 13474411
    [No Abstract]   [Full Text] [Related]  

  • 2. [The use of streptomycin aerosols and hyaluronidase in the treatment of chronic cavitary pulmonary tuberculosis].
    VIDAL MJ; HUSSON M
    Mars Med; 1954; 91(2):178-9. PubMed ID: 13164534
    [No Abstract]   [Full Text] [Related]  

  • 3. [Combined streptomycin, PAS and tibone therapy of pulmonary tuberculosis].
    KARTSIVADZE RE
    Probl Tuberk; 1955; 2():29-33. PubMed ID: 14384801
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of streptomycin and hyalurodinase aerosols in treatment of chronic cavitary pulmonary tuberculosis].
    VIDAL J; HUSSON H
    Montp Med; 1954 Apr; 45(4):370-3. PubMed ID: 13203464
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative effects of combined and continuous streptomycin-PAS and streptomycin-PAS-isoniazid therapy on closure of tuberculous caverns].
    MOREAU F
    Acta Tuberc Belg; 1957 Oct; 48(5):382-6. PubMed ID: 13497820
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies on the changes of the daily amount of tubercle bacilli present in sputum and its resistance against drugs, when patients have been treated with anti-tuberculous agents. III. Combined therapy with streptomycin, PAS and isoniazid].
    KAMEYAMA Y
    Kekkaku; 1958 Aug; 33(8):529-32; English abstract, 577-8. PubMed ID: 13588759
    [No Abstract]   [Full Text] [Related]  

  • 7. [Streptomycin, PAS and TB 1 in pulmonary tuberculosis].
    DE LOS RIOS LECHUGA F
    Med Cir Guerra; 1952 Jan; 14(1):27-38. PubMed ID: 14910094
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of pulmonary tuberculosis with PAS, isoniazid and streptomycin by venous infusions. Hematic concentrations and clinical results].
    SALVETTI F; BILLIA P
    Minerva Med; 1961 May; 52():1838-47. PubMed ID: 13745810
    [No Abstract]   [Full Text] [Related]  

  • 9. [Quantitative changes of neurotrophils in streptomycin and PAS therapy of pulmonary tuberculosis].
    GLEBOVICH OV
    Probl Tuberk; 1957; 35(3):58-62. PubMed ID: 13484931
    [No Abstract]   [Full Text] [Related]  

  • 10. Hydrocortisone aerosol combined with chemo-antibiotic therapy in the treatment of cavitary pulmonary tuberculosis.
    CIAMILLO E; LAUS S
    Riforma Med; 1959 May; 73(20):555-7. PubMed ID: 13675679
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of intravenous PAS in the treatment of pulmonary tuberculosis].
    ZUCALI A
    Lotta Tuberc; 1954; 24(10-11):921-9. PubMed ID: 14369022
    [No Abstract]   [Full Text] [Related]  

  • 12. [Intravenous PAS treatment in combination with other tuberculostatics in cavernous pulmonary tuberculosis].
    BRANDSCHWEDE S
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1957; 117(3):350-72. PubMed ID: 13522549
    [No Abstract]   [Full Text] [Related]  

  • 13. An evaluation of chemotherapy in pulmonary tuberculosis. II. Daily streptomycin plus high doses of isoniazid with PAS and pyridoxine.
    BERTE SJ; DEWLETT HJ; SCHMIDT HW
    Am Rev Tuberc; 1958 Nov; 78(5):779-84. PubMed ID: 13583443
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapeutic results in pulmonary tuberculosis patients with PAS perfusion].
    LUPIERI S
    Friuli Med; 1954; 9(6):721-6. PubMed ID: 14366038
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of an antitoxin, administered for a month, on the course of cavitary pulmonary tuberculosis presently refractory to antibacterial drugs. Contribution to the use of oxynhyles (stimulative substances)].
    FAVEZ G; TATTI V; BOREL C; VANNOTTI A; FREI J
    Schweiz Med Wochenschr; 1961 Feb; 91():183-7. PubMed ID: 13698406
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of pulmonary tuberculosis with high dosage of isoniazid derivative (Na-methansulfonate-IHMS) combined with PAS. The results of primary treatment of infiltrative caseous lesions].
    OHSATO T
    Kekkaku; 1960 Oct; 35():668-74. PubMed ID: 13730529
    [No Abstract]   [Full Text] [Related]  

  • 17. [Studies on the changes of the daily amount of tubercle bacilli present in sputum and their resistance against drugs, when patients have been treated with antituberculous agents. II. Combined therapy with SM-PAS: PAS-INH: SM-INH: or sulfisoxazol-INH].
    KAMEYAMA Y
    Kekkaku; 1958 Jul; 33(7):457-63; English abstract 517-8. PubMed ID: 13564630
    [No Abstract]   [Full Text] [Related]  

  • 18. [Statistical results of treatment of cavitary pulmonary tuberculosis with tuberculous allergen].
    GRAOVAC B
    Tuberkuloza; 1953; 5(5-6):416-31. PubMed ID: 13169292
    [No Abstract]   [Full Text] [Related]  

  • 19. Delta cortisone in the treatment of pulmonary tuberculosis; clinical and biological study.
    BROCARD H; GRIVAUX M
    Therapie; 1957; 12(1):26-38. PubMed ID: 13433661
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prednisone and prednisolone, anti-reactive elective drugs in pulmonary tuberculosis].
    REALE M; GARAVENTA A; PAOLI G; COSTA G
    Minerva Med; 1956 Jun; 47(45):1764-73. PubMed ID: 13348299
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.